TheStreet Ratings

10 Best Biotech Stocks for 2016 - Top Stocks - TheStreet Ratings

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks, by industry. The following biotech stocks are rated highest by our value-focused model. This list will be updated as upgrades and downgrades occur.

Equity Top: Biotechnology



Source: TheStreet Ratings

Best Investments for

Biotechnology News

Shares are Biogen spiked on the aducanumab data leak as investors with unfair access to what was supposed to be embargoed results traded on the information.
12/8/16 3:47PM
Voyager's gene therapy aims to turn back the clock so advanced Parkinson's patients respond better and longer to the standard drug used to treat the brain disease.
12/7/16 4:05PM
Cascadian's tucatinib delays regrowth of breast cancer by a median of 7.8 months in newly updated study results presented this week.
12/7/16 7:00AM
I spent the weekend with thousands of blood disease researchers. This is what happened.
12/5/16 1:11PM
Juno now finds itself one year, if not two years or more, behind rivals Novartis and Kite.
12/5/16 7:15AM
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
12/4/16 1:13PM
A nanotechnology derived artificial red blood cell could be used in life-saving situations like trauma accidents or the battlefield where donated blood is unavailable.
12/3/16 1:19PM
Spark believes temporary treatment with steroids can arrest the immune response before it causes factor IX levels to fall to a point where bleeding risk becomes a problem.
12/3/16 1:04PM
'We're seeing impressive, early responses with BB2121 without the toxicity,' says Bluebird CEO Nick Leschly.
11/30/16 5:20PM
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
11/30/16 8:34AM
CytRx announced a plan Tuesday to seek U.S. marketing approval of aldoxorubicin based more on hocus-pocus than credible study results.
11/29/16 8:59AM
The U.S. Food and Drug Administration turned down Amicus' request to seek accelerated approval for Galafold based on an existing kidney biomarker data.
11/28/16 4:34PM
Interpreting 'K-M curves' correctly is an important tool for biotech investors.
11/23/16 11:26AM
Juno Therapeutics halted a clinical trial involving its most advanced CAR-T therapy for the second time in five months after another two cancer patients developing brain swelling.
11/23/16 8:32AM
Based on the negative study results, Lilly will not pursue regulatory approvals for solanezumab in Alzheimer's disease.
11/23/16 8:07AM